COMBINATION OF ORGANIC COMPOUNDS

摘要

The present invention relates to a pharmaceutical combination comprising: (a) a pyrimidylaminobenzamide derivative compound or 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide (Imatinib which is sold under the name Gleevec®); and (b) the compound of the formula (IV) and the uses of such a combination for the treatment of proliferative diseases.